Today

Agents

Chat

Arena

Discover

More

App

Rani Therapeutics CEO Imran Talat acquires 35,000 shares worth $25,193 - RANI News | Rallies

Rani Therapeutics CEO Imran Talat acquires 35,000 shares worth $25,193

RANI•2026-07-21

Direct holding rises after purchase

Talat’s direct holding increased to 469,736 Class A common shares.

CEO buys 35,000 shares in open-market purchase

Rani Therapeutics CEO Imran Talat bought 35,000 Class A common shares in an open-market purchase.

The purchase price was $0.72 per share.

Related News

Charles Schwab MD Jonathan S. Beatty disposes of 2,000 common shares worth $208,411 by trust

SCHW•2026-07-21

Alaska Air Group - Airlines To Add Four 737-800 Freighters, Expanding Fleet To Nine

ALK•2026-07-21

Nano Dimension Announces Appointment Of Interim Chief Executive Officer And Chairman Of The Board

Sources

S

Rani Therapeutics CEO Imran Talat acquires 35,000 shares worth $25,193

Sec

NNDM•2026-07-21

Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares

BOLD•2026-07-21

Galaxy Gaming Announces Termination Of Merger With Evolution

GLXZ•2026-07-21